Health
WHO requested detailed information from China on respiratory disease outbreaks
The World Health Organisation has asked China for details on the rise in respiratory diseases and reported clusters of pneumonia in children in what its
Indonesian documents reveal events leading to cough syrup deaths
Indonesian court documents have for the first time revealed the chain of events that led to the use of toxic ingredients in cough syrup, one
Texas AG sues Pfizer over quality control violations for paediatric ADHD drug
Texas Attorney General Ken Paxton accused Pfizer and its supplier Tris Pharma of providing children’s ADHD medications they knew might be ineffective for the state’s
Monsanto sentenced to pay $165 million over circuit boards at Seattle school
A jury in the US has ordered Monsanto, owned by Bayer, to pay $165 million to employees at a school northeast of Seattle who claimed
The European Patent Office has invalidated Moderna’s mRNA patent
The European Patent Office has invalidated a contested mRNA patent owned by Moderna, the office said Tuesday, handing a victory to BioNTech and its partner
FDA cautions against the use of Cardinal syringes
The U.S. Food and Drug Administration on Monday warned healthcare providers and facilities not to use Cardinal Health’s Monoject syringes with patient-controlled anaesthetic pumps and
US FDA to delay decision on Bristol Myers-2seventy cancer biotherapies
US health regulators will not meet a 16 December deadline to decide on the expanded use of Bristol Myers Squibb and partner 2seventy bio’s blood
Croatia reports bird flu outbreak
Croatia has reported an outbreak of the H5N1 highly pathogenic avian influenza virus in a poultry farm, the World Organisation for Animal Health (WOAH) said.
Bayer ordered to pay $1.56bn in the latest US trial over Roundup herbicide
A Missouri jury has ordered Bayer to pay $1.56 billion to four plaintiffs who claimed the company’s Roundup herbicide caused injuries, including cancer. The verdict
Researchers re-investigate Alzheimer’s vaccines
Innovative Alzheimer’s treatments that remove toxic proteins from the brain have reignited interest in vaccines to treat the memory-destroying disease, potentially offering a cheaper and